BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mark C, Gupta S, Punnett A, Upton J, Orkin J, Atkinson A, Clarke L, Heisey A, McGovern C, Alexander S. Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase. Pediatr Blood Cancer 2021;:e29295. [PMID: 34398511 DOI: 10.1002/pbc.29295] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Greenhawt M, Shaker M, Golden DBK, Abrams EM, Blumenthal KG, Wolfson AR, Stone CA Jr, Krantz MS, Chu DK, Dwamena BA. Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis. Allergy 2023;78:71-83. [PMID: 36321821 DOI: 10.1111/all.15571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Keshavarz S, Keshavarz S, Ziamajidi N, Daei S. Immune Response to COVID-19 Vaccination in Hematologic Malignancies: A Mini-Review. Chonnam Med J 2023;59:24. [DOI: 10.4068/cmj.2023.59.1.24] [Reference Citation Analysis]
3 Khalid MB, Frischmeyer-Guerrerio PA. "The Conundrum of COVID-19 mRNA Vaccine-Induced Anaphylaxis". J Allergy Clin Immunol Glob 2022. [PMID: 36532656 DOI: 10.1016/j.jacig.2022.10.003] [Reference Citation Analysis]
4 Broos N, Brigitha LJ, Schuurhof A, Rockmann-helmbach H, Tissing W, Pieters R, van der Sluis IM, Stadermann M. Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy. EJC Paediatric Oncology 2022. [DOI: 10.1016/j.ejcped.2022.100002] [Reference Citation Analysis]
5 Kelso JM. Literature review. Annals of Allergy, Asthma & Immunology 2022. [DOI: 10.1016/j.anai.2022.09.014] [Reference Citation Analysis]
6 Ma Y, Liu N, Zhong G, Wang D, Cao L, Bai S, Zhu P, Zhang A, Wang X. Parent Acceptance toward Inactivated COVID-19 Vaccination in Children with Acute Lymphoblastic Leukemia: The Power of Oncologist and Alliance. Vaccines (Basel) 2022;10. [PMID: 36560428 DOI: 10.3390/vaccines10122016] [Reference Citation Analysis]
7 Munblit D, Greenhawt M, Brough HA, Pushkareva A, Karimova D, Demidova A, Warner JO, Kalayci O, Sediva A, Untersmayr E, Rodriguez del Rio P, Vazquez‐ortiz M, Arasi S, Alvaro‐lozano M, Tsabouri S, Galli E, Beken B, Eigenmann PA. Allergic diseases and immunodeficiencies in children, lessons learnt from COVID ‐19 pandemic by 2022: A statement from the EAACI ‐section on pediatrics. Pediatric Allergy Immunology 2022;33. [DOI: 10.1111/pai.13851] [Reference Citation Analysis]
8 Corey KB, Koo G, Phillips EJ. Adverse Events and Safety of SARS-CoV-2 Vaccines: What’s New and What’s Next. The Journal of Allergy and Clinical Immunology: In Practice 2022;10:2254-2266. [DOI: 10.1016/j.jaip.2022.04.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hartono SP, Sharma HP, Bundy V, Thompkins JD, Kochis SR, Brooks JP. Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate. The Journal of Allergy and Clinical Immunology: In Practice 2022;10:2172-2175.e1. [DOI: 10.1016/j.jaip.2022.05.035] [Reference Citation Analysis]
10 Swanson HD, Hakim H, Hijano DR, Morton T, Cross S, Inaba H, Jeha S, Pui CH, Karol SE. Vaccines against SARS-CoV-2 are safe to administer in patients with antibodies to pegaspargase. Cancer Med 2023;12:1552-5. [PMID: 35837830 DOI: 10.1002/cam4.5011] [Reference Citation Analysis]
11 Copaescu AM, Rosa Duque JS, Phillips EJ. What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later. Ann Allergy Asthma Immunol 2022;129:40-51. [PMID: 35390476 DOI: 10.1016/j.anai.2022.03.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zarnegar-Lumley S, Stone CA Jr, Smith CM, Hall LL, Luck KE, Koo G, Plager JH, Phillips EJ, Friedman DL. Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity. Pediatr Blood Cancer 2022;69:e29686. [PMID: 35353440 DOI: 10.1002/pbc.29686] [Reference Citation Analysis]
13 Otani IM, Tsao LR, Tang M. Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics. Ann Allergy Asthma Immunol 2022;129:88-94.e1. [PMID: 35288274 DOI: 10.1016/j.anai.2022.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
14 Sadeghi S, Kalantari Y, Shokri S, Fallahpour M, Nafissi N, Goodarzi A, Valizadeh R. Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis. Journal of Clinical Virology 2022. [DOI: 10.1016/j.jcv.2022.105196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Cesaro S, Muggeo P, Zama D, Cellini M, Perruccio K, Colombini A, Carraro F, Petris MG, Petroni V, Mascarin M, Baccelli F, Soncini E, Mura R, La Spina M, Decembrino N, Burnelli R, Frenos S, Castagnola E, Faraci M, Meazza C, Barzaghi F, D'Amico MR, Capasso M, Calore E, Ziino O, Barone A, Compagno F, Luti L, Galaverna F, De Santis R, Brescia L, Meneghello L, Petrone A, Giurici N, Onofrillo D, Schumacher F, Mercolini F. Consensus on COVID-19 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology Oncology. J Clin Med 2022;11:1235. [PMID: 35268326 DOI: 10.3390/jcm11051235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Rush C, Faulk KE, Bradley ZK, Turner A, Krumins M, Greenhawt M. The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience. J Allergy Clin Immunol Pract 2022;10:630-2. [PMID: 34883262 DOI: 10.1016/j.jaip.2021.11.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Cesaro S, Muggeo P, Zama D, Cellini M, Perruccio K, Colombini A, Carraro F, Petris M, Petroni V, Mascarin M, Baccelli F, Soncini E, Mura R, Laspina M, Decembrino N, Burnelli R, Frenos S, Castagnola E, Faraci M, Meazza C, Barzaghi F, D’amico MR, Capasso M, Calore E, Ziino O, Barone A, Compagno F, Luti L, Galaverna F, De Santis R, Brescia L, Meneghello L, Petrone A, Giurici N, Schumacher F, Mercolini F. Consensus on COVID-19 vaccination in pediatric oncohematological patients, on behalf of infectious working group of Italian Association of Pediatric Hematology Oncology.. [DOI: 10.1101/2022.01.06.22268792] [Reference Citation Analysis]
18 Jeimy S, Wong T, Song C. Immediate reactions after mRNA SARS-CoV-2 vaccination. CMAJ 2021;193:E1842. [PMID: 34772737 DOI: 10.1503/cmaj.211581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Khandker SS, Godman B, Jawad MI, Meghla BA, Tisha TA, Khondoker MU, Haq MA, Charan J, Talukder AA, Azmuda N, Sharmin S, Jamiruddin MR, Haque M, Adnan N. A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues. Vaccines (Basel) 2021;9:1387. [PMID: 34960133 DOI: 10.3390/vaccines9121387] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]